Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
132.02
-0.92 (-0.69%)
At close: May 28, 2025, 4:00 PM
131.50
-0.52 (-0.39%)
After-hours: May 28, 2025, 5:30 PM EDT
Abbott Laboratories Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 13,502 | 13,402 | 5,723 | 6,933 | 7,071 | 4,495 | Upgrade
|
| Depreciation & Amortization | 3,169 | 3,218 | 3,243 | 3,267 | 3,538 | 3,327 | Upgrade
|
| Loss (Gain) From Sale of Assets | 482 | 482 | 126 | 215 | 55 | 425 | Upgrade
|
| Stock-Based Compensation | 658 | 673 | 644 | 685 | 640 | 546 | Upgrade
|
| Change in Accounts Receivable | -802 | -691 | -356 | -68 | -383 | -924 | Upgrade
|
| Change in Inventory | 97 | -58 | -232 | -1,413 | -456 | -493 | Upgrade
|
| Change in Accounts Payable | 356 | 356 | -760 | 420 | 1,288 | 1,766 | Upgrade
|
| Change in Income Taxes | -8,028 | -8,028 | -585 | -383 | -908 | -614 | Upgrade
|
| Change in Other Net Operating Assets | -484 | -796 | -542 | -75 | -312 | -627 | Upgrade
|
| Operating Cash Flow | 8,950 | 8,558 | 7,261 | 9,581 | 10,533 | 7,901 | Upgrade
|
| Operating Cash Flow Growth | 25.30% | 17.86% | -24.21% | -9.04% | 33.31% | 28.77% | Upgrade
|
| Capital Expenditures | -2,293 | -2,207 | -2,202 | -1,777 | -1,885 | -2,177 | Upgrade
|
| Cash Acquisitions | - | - | -877 | - | -187 | -42 | Upgrade
|
| Divestitures | 1 | 1 | 40 | 48 | 134 | 58 | Upgrade
|
| Investment in Securities | -105 | -141 | -116 | -33 | -96 | -73 | Upgrade
|
| Other Investing Activities | 14 | 9 | 22 | 22 | 26 | 19 | Upgrade
|
| Investing Cash Flow | -2,383 | -2,338 | -3,133 | -1,740 | -2,008 | -2,215 | Upgrade
|
| Short-Term Debt Issued | - | - | 21 | 47 | - | 2 | Upgrade
|
| Long-Term Debt Issued | - | 223 | 2 | 7 | 4 | 1,281 | Upgrade
|
| Total Debt Issued | 224 | 223 | 23 | 54 | 4 | 1,283 | Upgrade
|
| Short-Term Debt Repaid | - | -100 | - | - | -204 | - | Upgrade
|
| Long-Term Debt Repaid | - | -660 | -2,498 | -753 | -48 | -1,333 | Upgrade
|
| Total Debt Repaid | -1,670 | -760 | -2,498 | -753 | -252 | -1,333 | Upgrade
|
| Net Debt Issued (Repaid) | -1,446 | -537 | -2,475 | -699 | -248 | -50 | Upgrade
|
| Issuance of Common Stock | 417 | 264 | 167 | 167 | 255 | 245 | Upgrade
|
| Repurchase of Common Stock | -1,349 | -1,295 | -1,227 | -3,795 | -2,299 | -403 | Upgrade
|
| Common Dividends Paid | -3,905 | -3,836 | -3,556 | -3,309 | -3,202 | -2,560 | Upgrade
|
| Other Financing Activities | - | - | - | - | - | -11 | Upgrade
|
| Financing Cash Flow | -6,283 | -5,404 | -7,091 | -7,636 | -5,494 | -2,779 | Upgrade
|
| Foreign Exchange Rate Adjustments | -36 | -96 | -23 | -122 | -70 | 71 | Upgrade
|
| Net Cash Flow | 248 | 720 | -2,986 | 83 | 2,961 | 2,978 | Upgrade
|
| Free Cash Flow | 6,657 | 6,351 | 5,059 | 7,804 | 8,648 | 5,724 | Upgrade
|
| Free Cash Flow Growth | 35.22% | 25.54% | -35.17% | -9.76% | 51.08% | 27.26% | Upgrade
|
| Free Cash Flow Margin | 15.72% | 15.14% | 12.61% | 17.88% | 20.08% | 16.54% | Upgrade
|
| Free Cash Flow Per Share | 3.81 | 3.63 | 2.89 | 4.42 | 4.83 | 3.21 | Upgrade
|
| Cash Interest Paid | 604 | 604 | 662 | 563 | 544 | 549 | Upgrade
|
| Cash Income Tax Paid | 1,753 | 1,723 | 1,475 | 1,864 | 1,941 | 970 | Upgrade
|
| Levered Free Cash Flow | 6,032 | 5,610 | 4,990 | 7,340 | 7,675 | 5,269 | Upgrade
|
| Unlevered Free Cash Flow | 6,376 | 5,959 | 5,389 | 7,689 | 8,009 | 5,610 | Upgrade
|
| Change in Net Working Capital | 66 | 410 | 809 | 182 | 37 | -500 | Upgrade
|
Updated Apr 16, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.